Celldex Therapeutics, Inc. Gains 35.24%

Fri 21 Feb 20 at 05:30 PM
Celldex Therapeutics, Inc. Gains 35.24%

Celldex Therapeutics, Inc. (CLDX:NASDAQ) soared at $3.07, a gain of 35.2%. From Thu 30 Jan 20, the stock recorded 42.86% Up Days and 26.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Celldex Therapeutics, Inc. (CLDX:NASDAQ)

Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Share